Moderna’s Next-Generation COVID Shot Gets FDA Backing With Usage Limitations

Moderna; COVID-19 vaccine; FDA approval; mNEXSPIKE; mRNA-1283; next-generation vaccine; respiratory virus season; age restriction; underlying conditions; vaccine efficacy

Moderna Shares Fall as Company Withdraws Flu/COVID-19 Combination Vaccine Application

Moderna; mRNA-1083; combination vaccine; flu; COVID-19; FDA; Biologics License Application; vaccine efficacy; clinical trial; share price